UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Cut by Atria Investments Inc

Atria Investments Inc trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 74,562 shares of the healthcare conglomerate's stock after selling 12,129 shares during the quarter. Atria Investments Inc's holdings in UnitedHealth Group were worth $37,718,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the stock. Hudson Value Partners LLC lifted its stake in shares of UnitedHealth Group by 8.3% in the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate's stock valued at $625,000 after purchasing an additional 82 shares in the last quarter. Wealth Group Ltd. grew its stake in UnitedHealth Group by 4.0% during the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate's stock worth $1,039,000 after buying an additional 68 shares during the period. Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at $341,000. GSG Advisors LLC boosted its position in UnitedHealth Group by 14.4% during the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate's stock worth $435,000 after purchasing an additional 94 shares during the period. Finally, Catalyst Capital Advisors LLC raised its position in UnitedHealth Group by 8.4% in the third quarter. Catalyst Capital Advisors LLC now owns 2,393 shares of the healthcare conglomerate's stock valued at $1,399,000 after purchasing an additional 186 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $1.61 during trading on Wednesday, reaching $476.22. 3,636,081 shares of the company's stock traded hands, compared to its average volume of 4,991,972. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a 50 day moving average of $514.58 and a 200-day moving average of $554.81. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $438.25 billion, a P/E ratio of 30.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on UNH shares. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Finally, Stephens boosted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.